×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Virus Outbreak | Russia | Vaccine

Studies Clash on Russian Vaccine's Efficacy against Omicron

Studies Clash on Russian Vaccine's Efficacy against Omicron

Friday, 17 December 2021 10:00 AM EST

MOSCOW (AP) — The developer of Russia’s Sputnik V said Friday that its vaccine provides the best protection against the omicron variant of the coronavirus, disputing a Western study which found Sputnik produced no antibodies against the new variant.

The Gamaleya Institute and the Russian Direct Investment Fund, which bankrolled Sputnik V and its one-shot version called Sputnik Light, said in a statement that a preliminary laboratory study showed Sputnik V had “the best virus neutralization results against omicron in comparison with other vaccines”.

Russian President Vladimir Putin praised Sputnik V efficiency against omicron earlier Friday.

“Our Sputnik V is working well, and, perhaps, even more effective against the omicron than other vaccines used,” the president said during a congress of the Russian Union of Industrialists and Entrepreneurs.

Meanwhile, international researchers from the University of Washington and the Swiss drugmaker Humabs Biomed SA said in a study published Tuesday in pre-print and yet to be peer-reviewed that data they analyzed showed conflicting results.

The study, which used samples from health care workers in Buenos Aires, Argentina, who received Sputnik V, showed “no neutralizing activity against omicron.”

Russia has so far reported 25 cases of the omicron variant in the country, according to Deputy Prime Minister Tatiana Golikova.

Follow AP's coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic

© Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


GlobalTalk
The developer of Russia's Sputnik V said Friday that its vaccine provides the best protection against the omicron variant of the coronavirus, disputing a Western study which found Sputnik produced no antibodies against the new variant.The Gamaleya Institute and the Russian...
Virus Outbreak,Russia,Vaccine
214
2021-00-17
Friday, 17 December 2021 10:00 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved